WED-005 Current hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus across Europe
Anders Boyd, Pablo Ryan, Kathrin van Bremen, Alessandro Tavelli, Gilles Wandeler(University of Bern), Juan Berenguer(Hospital General Universitario Gregorio Marañón), Charlotte Lim, Luz Martín‐Carbonero, Kosh Agarwal(King's College Hospital), Charles Béguelin(University of Bern), Iwona Cielniak, Lutz Thomas, Marc van der Valk(Academic Medical Center), Jürgen Rockstroh(University of Bonn), Miłosz Parczewski, Antonella d’Arminio Monforte, Sanjay Bhagani
Cited by 1
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
|The Lancet Respiratory Medicine|2022|127